{"task_id": "9a4d90de8547186c", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 369/464)", "text": "r Science\u00feBusiness Media, LLC 2006, 2007, 2011\n361\n\n--- Page 383 ---\nSPECIFIC ENTITIES (CONT\u2019D)\n\u0002\nTREATMENTS\ntreat underlying cause. Leg elevation.\nSupportive stockings (after ankle brachial index\nchecked). Topical steroids for acute exacerbations\nSCABIES\n\u0002\nCLINICAL FEATURES\nexcoriations, eczematized and\nurticarial papules over trunk. Linear white burrows\nover finger webs, sides of hand, and flexural\naspects of wrists\nSPECIFIC ENTITIES (CONT\u2019D)\n\u0002\nTREATMENTS\nfirst line therapy with permethrin 5%\ncream \u00031 dose, rinse off after 8 14 h. Second line\ntreatments include ivermectin 200 mcg/kg PO \u00031\ndose and repeat PO \u00031 dose 2 weeks later, lindane\n1% lotion or cream \u00031 dose, rinse off after 8 h, and\nbenzyl benzoate 10 or 25% lotions \u00031 dose, rinse\noff after 24 h\nNEJM 2006 354:16\nPsoriasis Vulgaris\nDIFFERENTIAL DIAGNOSIS OF PAPULOSQUAMOUS\nLESIONS\nINFLAMMATORY\npsoriasis vulgaris, lichen pla\nnus, nummular eczema, discoid lupus\nINFECTIONS\ntinea, pityriasis rosea, secondary\nsyphilis, seborrheic dermatitis\nMALIGNANCY\nmycosis fungoides, basal cell car\ncinoma, squamous cell carcinoma\nIATROGENIC\ndrug eruption\nPATHOPHYSIOLOGY\nINFLAMMATION\na chronic inflammatory skin dis\norder with a polygenic predisposition and sometimes\nan environmental triggering factor (trauma/Koebner\nphenomenon, infections, drugs, alcohol ingestion,\nemotional stress)\nCLINICAL FEATURES\nFINDINGS\nwell circumscribed, bright salmon red\ncolor, silvery micaceous scaly plaques. Predilection\nfor the scalp and extensor regions. Nails may show\npitting changes, \u2018\u2018oil spots\u2019, onycholysis, and subun\ngual debris which may be helpful in making the\ndiagnosis. All patients regardless of skin severity\nshould be screened for arthritis that is often worse\nin the mornings and shows asymmetric swelling of\njoints. Consider screening for hyperlipidemia, coron\nary artery disease, and diabetes in patients with risk\nfactors as there is an increased predilection in\npatients with psoriasis\nSUBTYPES\n\u0002\nCHRONIC PLAQUE PSORIASIS\npredilection for scalp,\nelbows, and knees. Symmetric, sharply demar\ncated erythematous plaques with silvery scales\nthat when scratched off reveals punctate blood\ndroplets (Auspitz sign)\n\u0002\nGUTTATE PSORIASIS\npredilection for trunk. May\nfollow a streptococcal infection. Multiple discrete\nerythematous papules with silvery scales\n\u0002\nPALMOPLANTAR PSORIASIS\nmild to severe forms.\nWell demarcated erythematous plaque with silver\nCLINICAL FEATURES (CONT\u2019D)\nscales. Cracking, fissures, or bleeding may be seen.\nPustular variant also found\n\u0002\nINVERSE PSORIASIS\nperianal, genital, and axillary\nwell demarcated erythematous plaques that are\nmore likely to be macerated and fissured due to\nlocation in a moist and warm environment\n\u0002\nERYTHRODERMIC PSORIASIS\ngeneralized erythema \u0004\ncharacteristic erythematous plaques with white sil\nver scale and nail changes. Often spares the face\n\u0002\nPUSTULAR PSORIASIS\ninitial stinging and burning\nin area may promote scratching, followed by erup\ntion of sterile pustules\nINVESTIGATIONS\nSPECIAL (not typically performed)\n\u0002\nMICROBIOLOGY\nthroat C&S (if guttate psoriasis)\n\u0002 KOH PREPARATION\nif suspect tinea\n\u0002\nSKIN BIOPSY\nMANAGEMENT\nTREAT UNDERLYING CAUSE\ntopical therapy with\ncorticosteroids (triamcinolone/fluocinolone, fluocino\nnide, and clobetasol) and vitamin D analogs. If unable\nto control, light therapy with either UVB or PUVA may\nbe considered, but requires 2 3 visits/week for\nmonths. Traditional systemic therapies including aci\ntretin, cyclosporine, and methotrexate should be con\nsidered in patients with moderate to severe psoriasis\nwith >10% body surface involvement or severe func\ntional impairment (hands, feet, arthritis, and genitals).\nIf unresponsive or unable to tolerate these, biologic\ntherapy such as the TNFa inhibitors should be con\nsidered. Avoid systemic steroids as discontinuation\nmay cause generalized pustular psoriasis\nSPECIFIC ENTITIES\nPITYRIASIS ROSEA\n\u0002\nPATHOPHYSIOLOGY\nhuman herpesvirus 7 may be\nthe etiologic agent, although this disorder does\nnot seem to be contagious\n362\nPsoriasis Vulgaris", "text_length": 4029, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 369/464)", "type": "chunk", "chunk_index": 368, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.757910", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.758743", "status": "complete"